Cyclin-dependent kinase 4 inhibitor a and tumor

被引:0
|
作者
Gong, Z. [1 ]
Fu, J. [1 ]
机构
[1] Medical Genetics Department, Second Military Medical University, Shanghai 200433, China
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Tumors
引用
收藏
页码:219 / 221
相关论文
共 50 条
  • [31] CYCLIN-DEPENDENT KINASE REGULATION
    LEES, E
    CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (06) : 773 - 780
  • [32] THE CYCLIN-DEPENDENT KINASE FAMILY
    HARLOW
    HUNTER
    NASMYTH
    HUNT
    KIRSCHNER
    BEACH
    PINES
    REED
    YANAGIDA
    LEHNER
    CIBA FOUNDATION SYMPOSIA, 1992, 170 : 205 - 208
  • [33] THE CYCLIN-DEPENDENT KINASE FAMILY
    MEYERSON, M
    FAHA, B
    SU, LK
    HARLOW, E
    TSAI, LH
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1991, 56 : 177 - 186
  • [34] Cyclin-dependent kinase inhibitors
    Westwell, A
    DRUG DISCOVERY TODAY, 2001, 6 (09) : 491 - 491
  • [35] Cyclin-dependent kinase 4 inhibits hepatic gluconeogenesis
    Giralt, A.
    Denechaud, P. -D.
    Lagarrigue, S.
    Lopez, I.
    Hure, S.
    Chavey, C.
    Fajas, L.
    DIABETOLOGIA, 2013, 56 : S281 - S281
  • [36] Cyclin-dependent kinase inhibitors
    Dai, Y
    Grant, S
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (04) : 362 - 370
  • [37] Proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in normal and tumor cells
    Mercurio, C
    Fiore, F
    Goubin, F
    Loda, M
    Pagano, M
    Draetta, GF
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 93 - 93
  • [38] Expression and significance of cyclin D1, cyclin-dependent kinase 4 and cyclin-dependent kinase inhibitor P27 in patients with non-neoplastic epithelial disorders of the vulva
    Liu, Huamei
    Zhang, Fan
    Li, Zongheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (01)
  • [39] Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment
    Pandey, Pratibha
    Khan, Fahad
    Upadhyay, Tarun Kumar
    Sharangi, Amit Baran
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [40] Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits
    Eva-Maria D. Nielsen
    Lars Hansen
    Trine Stissing
    Keiko Yanagisawa
    Knut Borch-Johnsen
    Pernille Poulsen
    Allan Vaag
    Torben Hansen
    Oluf Pedersen
    Journal of Molecular Medicine, 2005, 83 : 353 - 361